Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414

Recently, Menzel A et al. published a review titled “Origin and Physiological Aspects of Oxidative Stress (OS), inflammation and markers of OS, relation to disease and practical aspects” [...]

Bibliographic Details
Main Authors: Simona Mrakic-Sposta, Maristella Gussoni, Michela Montorsi, Alessandra Vezzoli
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Antioxidants
Subjects:
n/a
Online Access:https://www.mdpi.com/2076-3921/10/6/836
_version_ 1797532900144447488
author Simona Mrakic-Sposta
Maristella Gussoni
Michela Montorsi
Alessandra Vezzoli
author_facet Simona Mrakic-Sposta
Maristella Gussoni
Michela Montorsi
Alessandra Vezzoli
author_sort Simona Mrakic-Sposta
collection DOAJ
description Recently, Menzel A et al. published a review titled “Origin and Physiological Aspects of Oxidative Stress (OS), inflammation and markers of OS, relation to disease and practical aspects” [...]
first_indexed 2024-03-10T11:06:56Z
format Article
id doaj.art-fbd2dcbb9bdc44baa2f6bc601bd25658
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T11:06:56Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-fbd2dcbb9bdc44baa2f6bc601bd256582023-11-21T21:06:44ZengMDPI AGAntioxidants2076-39212021-05-0110683610.3390/antiox10060836Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414Simona Mrakic-Sposta0Maristella Gussoni1Michela Montorsi2Alessandra Vezzoli3National Research Council—Institute of Clinical Physiology (CNR-IFC), 20162 Milan, ItalyNational Research Council—Institute of Chemical Sciences and Technologies “G. Natta”-SCITEC (CNR-SCITEC), 20133 Milan, ItalyDepartment of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, 20122 Milan, ItalyNational Research Council—Institute of Clinical Physiology (CNR-IFC), 20162 Milan, ItalyRecently, Menzel A et al. published a review titled “Origin and Physiological Aspects of Oxidative Stress (OS), inflammation and markers of OS, relation to disease and practical aspects” [...]https://www.mdpi.com/2076-3921/10/6/836n/a
spellingShingle Simona Mrakic-Sposta
Maristella Gussoni
Michela Montorsi
Alessandra Vezzoli
Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414
Antioxidants
n/a
title Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414
title_full Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414
title_fullStr Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414
title_full_unstemmed Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414
title_short Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414
title_sort comment on menzel et al common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice which to use regarding disease outcomes i antioxidants i 2021 i 10 i 414
topic n/a
url https://www.mdpi.com/2076-3921/10/6/836
work_keys_str_mv AT simonamrakicsposta commentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesiantioxidantsi2021i10i414
AT maristellagussoni commentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesiantioxidantsi2021i10i414
AT michelamontorsi commentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesiantioxidantsi2021i10i414
AT alessandravezzoli commentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesiantioxidantsi2021i10i414